These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 20570909

  • 1. Increased cancer predisposition in family members of colorectal cancer patients harboring the p.V600E BRAF mutation: a population-based study.
    Wish TA, Hyde AJ, Parfrey PS, Green JS, Younghusband HB, Simms MI, Fontaine DG, Dicks EL, Stuckless SN, Gallinger S, McLaughlin JR, Woods MO, Green RC.
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1831-9. PubMed ID: 20570909
    [Abstract] [Full Text] [Related]

  • 2. Somatic BRAF-V600E mutations in familial colorectal cancer.
    Vandrovcova J, Lagerstedt-Robinsson K, Påhlman L, Lindblom A.
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2270-3. PubMed ID: 17119056
    [Abstract] [Full Text] [Related]

  • 3. Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis.
    Hughes LA, Williamson EJ, van Engeland M, Jenkins MA, Giles GG, Hopper JL, Southey MC, Young JP, Buchanan DD, Walsh MD, van den Brandt PA, Alexandra Goldbohm R, Weijenberg MP, English DR.
    Int J Epidemiol; 2012 Aug; 41(4):1060-72. PubMed ID: 22531127
    [Abstract] [Full Text] [Related]

  • 4. BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis.
    Kalady MF, Dejulius KL, Sanchez JA, Jarrar A, Liu X, Manilich E, Skacel M, Church JM.
    Dis Colon Rectum; 2012 Feb; 55(2):128-33. PubMed ID: 22228154
    [Abstract] [Full Text] [Related]

  • 5. Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype.
    English DR, Young JP, Simpson JA, Jenkins MA, Southey MC, Walsh MD, Buchanan DD, Barker MA, Haydon AM, Royce SG, Roberts A, Parry S, Hopper JL, Jass JJ, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1774-80. PubMed ID: 18628431
    [Abstract] [Full Text] [Related]

  • 6. BRAF mutation is associated with the CpG island methylator phenotype in colorectal cancer from young patients.
    Ang PW, Li WQ, Soong R, Iacopetta B.
    Cancer Lett; 2009 Jan 18; 273(2):221-4. PubMed ID: 18778891
    [Abstract] [Full Text] [Related]

  • 7. The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status.
    Dahlin AM, Palmqvist R, Henriksson ML, Jacobsson M, Eklöf V, Rutegård J, Oberg A, Van Guelpen BR.
    Clin Cancer Res; 2010 Mar 15; 16(6):1845-55. PubMed ID: 20197478
    [Abstract] [Full Text] [Related]

  • 8. Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer.
    Seppälä TT, Böhm JP, Friman M, Lahtinen L, Väyrynen VM, Liipo TK, Ristimäki AP, Kairaluoma MV, Kellokumpu IH, Kuopio TH, Mecklin JP.
    Br J Cancer; 2015 Jun 09; 112(12):1966-75. PubMed ID: 25973534
    [Abstract] [Full Text] [Related]

  • 9. Frequency and application of the hot spot BRAF gene mutation (p.V600E) in the diagnostic strategy for Hereditary Nonpolyposis Colorectal Cancer.
    Kadiyska TK, Konstantinova DV, Atanasov VR, Kremensky IM, Mitev VI.
    Cancer Detect Prev; 2007 Jun 09; 31(3):254-6. PubMed ID: 17566669
    [Abstract] [Full Text] [Related]

  • 10. Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer.
    Zlobec I, Kovac M, Erzberger P, Molinari F, Bihl MP, Rufle A, Foerster A, Frattini M, Terracciano L, Heinimann K, Lugli A.
    Int J Cancer; 2010 Dec 01; 127(11):2569-75. PubMed ID: 20162668
    [Abstract] [Full Text] [Related]

  • 11. BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations.
    Preto A, Figueiredo J, Velho S, Ribeiro AS, Soares P, Oliveira C, Seruca R.
    J Pathol; 2008 Feb 01; 214(3):320-7. PubMed ID: 18098337
    [Abstract] [Full Text] [Related]

  • 12. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study.
    Balaguer F, Castellví-Bel S, Castells A, Andreu M, Muñoz J, Gisbert JP, Llor X, Jover R, de Cid R, Gonzalo V, Bessa X, Xicola RM, Pons E, Alenda C, Payá A, Piqué JM, Gastrointestinal Oncology Group of the Spanish Gastroenterological Association.
    Clin Gastroenterol Hepatol; 2007 Mar 01; 5(3):379-87. PubMed ID: 17368238
    [Abstract] [Full Text] [Related]

  • 13. Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors.
    Aaltonen L, Johns L, Järvinen H, Mecklin JP, Houlston R.
    Clin Cancer Res; 2007 Jan 01; 13(1):356-61. PubMed ID: 17200375
    [Abstract] [Full Text] [Related]

  • 14. Oligonucleotide microarray analysis of distinct gene expression patterns in colorectal cancer tissues harboring BRAF and K-ras mutations.
    Kim IJ, Kang HC, Jang SG, Kim K, Ahn SA, Yoon HJ, Yoon SN, Park JG.
    Carcinogenesis; 2006 Mar 01; 27(3):392-404. PubMed ID: 16219636
    [Abstract] [Full Text] [Related]

  • 15. Analysis of DNA mismatch repair proteins expression and BRAF V600E mutation in a subset of early- and late-onset colorectal carcinoma patients in Mexico.
    Luévano-González A, Guzmán AQ, Ancer Rodríguez J, Ortiz López R, Rojas Martínez A, González Guerrero JF, Flores Gutiérrez JP.
    Arch Med Res; 2011 Aug 01; 42(6):457-62. PubMed ID: 21945875
    [Abstract] [Full Text] [Related]

  • 16. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.
    Domingo E, Laiho P, Ollikainen M, Pinto M, Wang L, French AJ, Westra J, Frebourg T, Espín E, Armengol M, Hamelin R, Yamamoto H, Hofstra RM, Seruca R, Lindblom A, Peltomäki P, Thibodeau SN, Aaltonen LA, Schwartz S.
    J Med Genet; 2004 Sep 01; 41(9):664-8. PubMed ID: 15342696
    [Abstract] [Full Text] [Related]

  • 17. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
    Johnson V, Lipton LR, Cummings C, Eftekhar Sadat AT, Izatt L, Hodgson SV, Talbot IC, Thomas HJ, Silver AJ, Tomlinson IP.
    J Med Genet; 2005 Oct 01; 42(10):756-62. PubMed ID: 15788729
    [Abstract] [Full Text] [Related]

  • 18. Combined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancer.
    Ooki A, Akagi K, Yatsuoka T, Asayama M, Hara H, Takahashi A, Kakuta M, Nishimura Y, Yamaguchi K.
    J Surg Oncol; 2014 Dec 01; 110(8):982-8. PubMed ID: 25154726
    [Abstract] [Full Text] [Related]

  • 19. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
    Goel A, Nagasaka T, Arnold CN, Inoue T, Hamilton C, Niedzwiecki D, Compton C, Mayer RJ, Goldberg R, Bertagnolli MM, Boland CR.
    Gastroenterology; 2007 Jan 01; 132(1):127-38. PubMed ID: 17087942
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancer.
    Nakaji Y, Oki E, Nakanishi R, Ando K, Sugiyama M, Nakashima Y, Yamashita N, Saeki H, Oda Y, Maehara Y.
    J Cancer Res Clin Oncol; 2017 Jan 01; 143(1):151-160. PubMed ID: 27672042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.